Skip to main content
Clinical Trials/NCT05501613
NCT05501613
Completed
Not Applicable

Early Multimodal Neuromonitoring Parameters as Prognostic Factors For Critically Ill Spontaneous ICH Patients

Universidade do Porto1 site in 1 country65 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intracerebral Hemorrhage
Sponsor
Universidade do Porto
Enrollment
65
Locations
1
Primary Endpoint
Survival
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.

Detailed Description

Retrospective observational study based on analyzing the first 48 hours of the multimodal neuromonitoring signal, from spontaneous ICH patients, whose treatment includes invasive intraparenchymal neuromonitoring, treated from January 2015 to September 2021 in a tertiary hospital.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
February 1, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ana Filipa Vaz Ferreira

Principal Investigator

Universidade do Porto

Eligibility Criteria

Inclusion Criteria

  • Spontaneous Intracerebral Hemorrhage
  • ICU admission
  • Need of Sedation and Ventilatory Support
  • Need of Intracerebral Neuromonitoring

Exclusion Criteria

  • Etiology for Intracerebral hemorrhage such as tumor, vascular malformation, ischemic transformation.

Outcomes

Primary Outcomes

Survival

Time Frame: 1 and 6 months

1 and 6 months survival

Functional Outcome

Time Frame: 6 month

6 month functional outcome with Modified Rankin Scale - 0 (No symptoms); 1 (No significant disability); 2 (Slight disability); 3 (Moderate disability); 4 (Moderately Severe Disability); 5 (Severe Disability); 6 (Dead).

Study Sites (1)

Loading locations...

Similar Trials